0000950170-23-062094 Sample Contracts

First Amendment to Exclusive License Agreement

License Agreement • November 9th, 2023 • Erasca, Inc. • Pharmaceutical preparations

• Contract Type
  License Agreement
• Filed
  November 9th, 2023
• Company
  Erasca, Inc.
• Industry
  Pharmaceutical preparations

This First Amendment to the Exclusive License Agreement (the “First Amendment”) effective as of August 7, 2023 (the “Amendment Effective Date”), is made by and between Erasca, Inc. (“Erasca”) and Novartis Pharma AG (“Novartis”) and amends the Exclusive License Agreement between the parties, dated December 9, 2022 (the “Agreement”).